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Summary and Overview: NIOSH Symposium
on Toxic Effects of Glycol Ethers
by Bryan D. Hardin* and James P Lyont
The papers contained in this issue of Environmental
Health Perspectives were presented at a symposium
sponsored by the National Institute for Occupational
Safety and Health (NIOSH) on September 19-21, 1983.
In his opening remarks, B. L. Johnson (NIOSH) listed
four objectives for this symposium. These were: (1) to
foster direct exchange between scientists who are
active in glycol ether research; (2) to summarize the
current state ofknowledge on glycol ether toxicity; (3)
to identify future research needs; and (4) to identify
actions needed to protect the health ofworkers exposed
to glycol ethers. The symposium was productive in all
these areas, involving investigators from government,
academic, and industrial laboratories. Speaking in be-
halfofthe Chemical Manufacturers Association Special
Project Panel on Glycol Ethers, J. P Lyon (ICI
Americas) described the Toxicology Research Task
Group's testing program. Data developed as part ofthis
industry initiative were presented throughout this
symposium.
R. L. Smith (Eastman Chemical Products, Inc.)
reviewed the basic uses of ethylene glycol ethers and
ether esters, especially in various surface coatings. The
combination of mild odor, low evaporation rate, good
solvent and couplingactivity, flow and leveling qualities,
blush resistance ('blushing" is the formation of a hazy
finish due to absorption of atmospheric moisture) and
solvent release (the ability ofthe solvent to escape from
beneath the surface film as acoatingdries) were cited as
a few of the factors which lead to the unique position
occupied by this class of compounds. Many of the
specific uses of ethylene glycol ethers are based on
a combination ofthese characteristics and were derived
through experience over many years. Product reformu-
lation to replace one material with another there-
fore cannot be a simple one-for-one exchange and
replacement of glycol ethers may be difficult in some
applications.
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Despite the widespread usage of ethylene glycol
ethers, D. E. Clapp (NIOSH) described serious diffi-
culties encountered by NIOSH when attempting to
identify an appropriate population for epidemiologic
study. One of these difficulties is the accurate descrip-
tion of worker exposure, which cannot be based solely
on airborne concentrations since many of the glycol
ethers penetrate the skin readily. As a potential solu-
tion to this problem, A. W Smallwood (NIOSH) dis-
cussed the progress made toward development ofmeth-
odsfortheanalysisofglycolethersandtheirmetabolites
in blood and urine.
Aseries ofpapers onteratogenicity testing, progress-
ingfrommethyl through butyl ethers ofethylene glycol,
was presented by T. R. Hanley (Dow Chemical Co.), F
D. Andrew (Syntex Research), W J. Krasavage
(Eastman Kodak Co.), J. E. Doe (Imperial Chemical
Industries, PLC), B. K. Nelson (NIOSH), R. W Tyl
(Bushy Run Research Center) and B. D. Hardin
(NIOSH). A consistent pattern of embryotoxic and
teratogenic effects in various species and following
diverse routes of exposure was described for ethylene
glycol monomethyl ether (EGME) and monoethyl ether
(EGEE). A similar spectrum ofeffects was reported for
ethylene glycol monoethyl ether acetate (EGEEA). For
higherethylene glycol ethers (monopropyl ether acetate
[EGPEA] and monobutyl ether [EGBE], maternal
toxicity appeared to dominate, particularly in the case
ofEGBE. Although isolated cardiovascular and skeletal
defects or variations ofnormal development were seen,
they seemed to be associated with maternal toxicity. T.
R. Hanley reported that propylene glycol monomethyl
ether (PGME), which was predominantly the 1-
methoxy-2-propanol isomer, had relatively low acute
maternal toxicity and was not teratogenic.
A variety of in vitro and mutagenesis tests were
reported. D. B. McGregor (Inveresk Research Inter-
national) and E. D. Thompson (Proctor and Gamble
Co.) each reported the apparent lack ofgenotoxicity in
the glycols tested: EGME, diethylene glycol dimethyl
ether (diEGdiME), and diethylene glycol monobutyl
ether (diEGBE). Invitro tests that may be predictive of
teratogenic activity were reported by R. Loch-Caruso
(Michigan State University), F Welsch (Chemical Indus-
try Institute of Toxicology) and E. M. JohnsonHARDIN AND LYON
(Jefferson Medical College). Using V79 hamster cells in
culture, Loch-Caruso reported inhibition of cell-cell
communication byethylene glycolandfourglycolethers.
Inhibition of intercellular communication fell and cyto-
toxicity increased as the molecular weight ofthe glycols
increased. These results can be interpreted as suggest-
ing that the lower molecular weight glycol ethers may
be tumor promoting agents. The parallels between
teratogenicity and activity in these tests of cell-cell
communication stimulate speculation that intercellular
communication may present a viable mechanistic basis
for the teratogenicity of glycol ethers. Welsch also
evaluated in vitro cell-cell communication, employing
human embryonal palatal mesenchyme cells. In this
system EGME inhibited intercellular communication by
apparently cytotoxic means. Ethylene glycol mono-
isopropyl ether, on the other hand, inhibited cell-cell
communication without cytotoxicity. Based on the ra-
tios of adult toxicity to developmental toxicity (A/D
ratios) in his Hydra attenuata system, Johnson con-
cluded that, ofthe 14 compounds (glycols, glycol ethers,
and ether acetates) tested in that system, EGEE
warranted the greatest concern. Others, including
EGME, were notidentified bythis system as possessing
unique developmental toxicity.
A short-term in vitro assay was reported by R. L.
Schuler (NIOSH). The results ofthese tests confirmed
the recognized embryotoxicity ofEGME, EGdiME, and
EGEE and suggested that mono- and dimethyl ether
derivatives of diethylene and triethylene glycol should
also be evaluated in detail. In similar in vivo studies,
Doe reported that neither PGME nor diEGME had
adverse effects on the outcome of pregnancy.
An unexpected observation in the in vivo assay
reported by Schuler was evidence that ethylene glycol
(EG) might itself be embryotoxic. Subsequent EG
studies, reported by J. C. Lamb (National Institute for
Environmental Health Sciences), in fact confirmed the
teratogenicity of EG. These studies involved both con-
ventional teratology in mice and rats, as well as a new
screening assay in which breeding pairs of mice are
cohabited for up to 120 days while being exposed to the
chemical in the drinking water. Remarkably similar
skeletal defects were reported in both species and in
both experimental protocols. The continuous breeding
protocol was also reported by Lamb to reveal antifertil-
ity effects of EGEE not only in males, as would have
been predicted, but also in females.
Studies ofthe testicular toxicity of a large number of
glycol ethers were summarized by K. Nagano (Japan
Bioassay Laboratory), whose 1979 publication stimu-
lated many of those in attendance to investigate the
glycol ethers. Declining testicular toxicity with increas-
ing substituent alkyl chain length was revealed by these
studies, as was the molar equivalence of two acetates
(EGMEA and EGEEA) with their corresponding glycol
ethers (EGME and EGEE). Both Nagano and Doe
presented evidence that EGPE and EGBE did not have
adverse effects on the testis. P M. D. Foster (British
Industrial Biological Research Association) and R. E.
Chapin (National Institute of Environmental Health
Sciences) presented detailed evaluations of the earliest
stages oftesticular pathology. Using EGME as a model
compound, they were able to demonstrate the remark-
able sensitivity of meiotic spermatocytes. Equivalent
doses ofmethoxy and ethoxy acetic acids were reported
to produce similar effects. Effects on Sertoli cell func-
tion were not detected. H. Zenick (University of
Cincinnati) reported wide-ranging studies ofthe effects
of EGEE on reproductive performance of male rats.
Observations included unusual abnormalities of sperm
head morphology caused by EGEE treatment.
The metabolism of ethylene glycol ethers was dis-
cussed by R. R. Miller (Dow Chemical) and H. B.
Plotnick (NIOSH), who have shown that metabolism
probably proceeds primarily by way of the alcohol/
aldehyde dehydrogenase system to yield alkoxyacetic
acid as the primary metabolite. Plotnick presented data
showing that cleavage of the ether linkage occurs as a
minor metabolic pathway and documented that urinary
excretion ofethoxyacetic acid and its glycine conjugate
accounts for the majority of an administered dose.
PGME, on the other hand, was shown by Miller to be
demethylated and excreted in urine primarily as propyl-
ene glycol. Foster demonstrated on the histologic level
that the in vivo effects of methoxyacetic acid parallel
those of EGME and showed that inhibition of alcohol
dehydrogenase protected against the testicular toxicity
of EGME, while inhibition of aldehyde dehydrogenase
did not prevent testicular toxicity.
The ability of glycol ethers to penetrate the skin in
toxic amounts has long been recognized. That rats can
absorb teratogenic doses ofEGEE and EGEEA by this
route was reported by B. D. Hardin (NIOSH). Quantita-
tive studies ofskin penetration by various glycol ethers
were presented by D. Guest (Eastman Kodak Co.) and
P Dugard (Imperial Chemical Industries, PLC). Radio-
labeled EGEEA and EGPEA were tested in beagle
dogs by Dr. Guest, who noted very similar rates of
percutaneous absorption. Dugard employed an in vitro
human skin preparation in which he was able to
determine with precision the kinetics of skin pene-
tration. In both the ethylene and diethylene glycol
series, the relative rate of absorption declined from
methyl to ethyl to butyl ether derivatives. Diethylene
glycol ethers were absorbed more slowly than the
corresponding ethylene glycol ethers.
The acute and subehronic toxicity of EGEE, EGPE
and EGBE was reviewed by C. C. Conaway (Texaco,
Inc.), G. V Katz (Eastman Kodak Co.) and T. Tyler
(Union Carbide Corporation). Reviews focused on toxic
effects and target organ specificity of these glycols
(kidneys, liver, hematopoietic system and red blood
cells). For EGBE it was suggested that current occupa-
tional exposure limits are adequate for protection of
human health.
Finally, there were several papers reviewing the
subchronic and chronic toxicity ofseveral glycol ethers.
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News of the chronic studies of EG and EGEE being
sponsored by the National Toxicology Program were
anxiously awaited. Histopathologic evaluations were
not complete, so R. L. Melnick (National Institute of
Environmental Health Sciences) was unable to report
conclusions regarding carcinogenicity. He did note,
however, that somegrosslesions (ofthe spleen, pituitary
and testis and in the mammary gland region offemales)
often seen at necropsy ofF344 rats were less common in
EGEE-treated animals. This observation is intriguing
in light of the report by D. P Houchens (Battelle
Columbus Laboratories) that EGME- and EGEE-
treated mice survived challenges with L1210 leukemia
cells that were fatal to untreated mice. These unex-
pected results were tentatively interpreted as suggest-
ing an enhancement by these glycol ethers of immune
function, since a direct cytotoxic effect on tumor cells
was not detected.
Overall, the symposium was a stimulating opportu-
nity for a profitable discussion of current research
activities. Some general concepts can be developed,
e.g., toxicologic equivalence on a molar basis of alkoxy
ethyl ether acetates with the corresponding alkoxy
ethyl ether; reproductive toxicity inversely related
to length of the substituted alkoxy group; biologic
activation of alkoxy ethyl ethers by metabolism to
alkoxy acetic acid. However, many questions remain
unanswered, such as the basic mechanisms by which the
cell-specific testicular effects are produced; the role, if
any, of cell-cell communication in the embryotoxicity
and teratogenicity of glycol ethers; the basis for and
consequences of the apparent enhancement of immune
function in glycol-treated mice.
Questions of a more immediate and practical nature
face the manyusers ofglycol ethers. Exposures must be
controlled to acceptable levels. Where exposure controls
are not feasible substitutes will be necessary. Alterna-
tive solvents with appropriate physical, chemical, and
solvent properties but lacking the reproductive toxicity
of EGME or EGEE must be found. The growth of
knowledge regarding biological activity has been rapid
inthepasttwotothreeyearsandpromisestoaccelerate.
Studies reported at this symposium will go far toward
providing a basis for the design offuture studies and for
making the best-informed business decisions possible
on exposure or substitutions.
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